Treatment with anti-IFNαβR mAb alone, anti-IFN-γ mAb alone, or both mAbs was tested either early after co-infection or at later time points, as in our earlier experiments with serotype 3 pneumococcus-CA04 virus superinfection (Fig 6). This evidence concerns the gene IFNAR2 and coinfection.